(Q44523467)

English

Formoterol (Foradil) and medium-high doses of inhaled corticosteroids are more effective than high doses of corticosteroids in moderate-to-severe asthma

scientific article published in January 2003

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

Formoterol (Foradil) and medium-high doses of inhaled corticosteroids are more effective than high doses of corticosteroids in moderate-to-severe asthma (English)

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

author name string

C Mitchell

1

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

C Jenkins

2

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

R Scicchitano

3

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

A Rubinfeld

4

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

J Kottakis

5

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

publication date

1 January 2003

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

Pulmonary Pharmacology & Therapeutics

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

16

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

5

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

299-306

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

Added salmeterol versus higher-dose corticosteroid in asthma patients with symptoms on existing inhaled corticosteroid. Allen & Hanburys Limited UK Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS1094-5539%2803%2900071-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of inhaled formoterol and budesonide on exacerbations of asthma. Formoterol and Corticosteroids Establishing Therapy (FACET) International Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS1094-5539%2803%2900071-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparison of salmeterol with beclomethasone in adult patients with mild persistent asthma who are already on low-dose inhaled steroids

1 reference

https://api.crossref.org/works/10.1016%2FS1094-5539%2803%2900071-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Concurrent use of salmeterol with inhaled corticosteroids is more effective than inhaled corticosteroid dose increases

1 reference

https://api.crossref.org/works/10.1016%2FS1094-5539%2803%2900071-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Addition of salmeterol versus doubling the dose of fluticasone propionate in patients with mild to moderate asthma

1 reference

https://api.crossref.org/works/10.1016%2FS1094-5539%2803%2900071-3

7 January 2021

based on heuristic

inferred from DOI database lookup

The addition of salmeterol to fluticasone propionate versus increasing the dose of fluticasone propionate in patients with persistent asthma. Salmeterol Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS1094-5539%2803%2900071-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Formoterol and beclomethasone versus higher dose beclomethasone as maintenance therapy in adult asthma

1 reference

https://api.crossref.org/works/10.1016%2FS1094-5539%2803%2900071-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Salmeterol added to inhaled corticosteroid therapy is superior to doubling the dose of inhaled corticosteroids: a randomized clinical trial.

1 reference

https://api.crossref.org/works/10.1016%2FS1094-5539%2803%2900071-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Salmeterol versus formoterol in patients with moderately severe asthma: onset and duration of action

1 reference

https://api.crossref.org/works/10.1016%2FS1094-5539%2803%2900071-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Time course and duration of bronchodilatation with formoterol dry powder in patients with stable asthma

1 reference

https://api.crossref.org/works/10.1016%2FS1094-5539%2803%2900071-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Meta-analysis of increased dose of inhaled steroid or addition of salmeterol in symptomatic asthma (MIASMA).

1 reference

https://api.crossref.org/works/10.1016%2FS1094-5539%2803%2900071-3

7 January 2021

based on heuristic

inferred from DOI database lookup

A long-term study of the antiinflammatory effect of low-dose budesonide plus formoterol versus high-dose budesonide in asthma.

1 reference

https://api.crossref.org/works/10.1016%2FS1094-5539%2803%2900071-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Low dose inhaled budesonide and formoterol in mild persistent asthma: the OPTIMA randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FS1094-5539%2803%2900071-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparison of addition of salmeterol to inhaled steroids with doubling of the dose of inhaled steroids

1 reference

https://api.crossref.org/works/10.1016%2FS1094-5539%2803%2900071-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Measuring the systemic effects of inhaled beclomethasone: timed morning urine collections compared with 24 hour specimens

1 reference

https://api.crossref.org/works/10.1016%2FS1094-5539%2803%2900071-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Covariate imbalance and random allocation in clinical trials

1 reference

https://api.crossref.org/works/10.1016%2FS1094-5539%2803%2900071-3

7 January 2021

based on heuristic

inferred from DOI database lookup

The graphical representation of clinical trials with particular reference to measurements over time

1 reference

https://api.crossref.org/works/10.1016%2FS1094-5539%2803%2900071-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Long-acting inhaled beta2-agonists in asthma therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1094-5539%2803%2900071-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Scientific rationale for inhaled combination therapy with long-acting beta2-agonists and corticosteroids

1 reference

https://api.crossref.org/works/10.1016%2FS1094-5539%2803%2900071-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Systemic adverse effects of inhaled corticosteroid therapy: A systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS1094-5539%2803%2900071-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinical outcome of adding long-acting beta-agonists to inhaled corticosteroids

1 reference

https://api.crossref.org/works/10.1016%2FS1094-5539%2803%2900071-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Salmeterol/fluticasone propionate (50/500 microg) in combination in a Diskus inhaler (Seretide) is effective and safe in the treatment of steroid-dependent asthma

1 reference

https://api.crossref.org/works/10.1016%2FS1094-5539%2803%2900071-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Evaluation of different inhaled combination therapies (EDICT): a randomised, double-blind comparison of Seretide (50/250 microg bd Diskus vs. formoterol (12 microg bd) and budesonide (800 microg bd) given concurrently (both via Turbuhaler) in patien

1 reference

https://api.crossref.org/works/10.1016%2FS1094-5539%2803%2900071-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Establishing a therapeutic index for the inhaled corticosteroids: part I. Pharmacokinetic/pharmacodynamic comparison of the inhaled corticosteroids

1 reference

https://api.crossref.org/works/10.1016%2FS1094-5539%2803%2900071-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Combined budesonide/formoterol turbuhaler treatment of asthma

1 reference

https://api.crossref.org/works/10.1016%2FS1094-5539%2803%2900071-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Inhaled salmeterol/fluticasone propionate combination: a review of its use in persistent asthma

1 reference

https://api.crossref.org/works/10.1016%2FS1094-5539%2803%2900071-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Exacerbations of asthma: a descriptive study of 425 severe exacerbations. The FACET International Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS1094-5539%2803%2900071-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S1094-5539(03)00071-3

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44523467&oldid=2026868647"